Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. are acting as joint book-running managers for the offering

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Solazyme Announces Pricing of Initial Public Offering. Solazyme, Inc., a renewable oil and bioproducts company, today announced the pricing of its initial public offering of 10,975,000 shares of common stock at a price to the public of $18.00 per share. Of the shares of common stock in the offering, Solazyme is offering 10,375,000 shares, and selling stockholders are offering 600,000 shares. I

Continue reading
www.businesswire.com/news/home/20110526007022/en/Solazyme-Announces-Pricing-Initial-Public-Offering